Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate as adjunct to weight loss in obese men with obstructive sleep apnea
ACTRN12606000404527Phase 3Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Sep 2006
- Countries
- 1
01
Overview
Phase 3, randomised trial in obesity and obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Testosterone undecanoate + weight reduction program with Placebo oil + weight reduction program (2 arms). Primary endpoint: Body weight change. Started Sep 2006; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
obesityobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12606000404527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000404527.